Taevas Global accelerates regulatory approval, distribution, and clinical adoption of medical devices across 24+ markets. From first submission to first sale, we manage every step in-country.

Securing regulatory clearance is only the first hurdle. Medical device manufacturers face fragmented distribution channels, complex hospital procurement cycles, and divergent post-market surveillance requirements across every target market. Without in-country expertise, even cleared devices stall before reaching clinical use.
Each market operates under distinct device classification systems, technical file requirements, and approval timelines. Navigating EU MDR, FDA 510(k), CDSCO, and NMPA simultaneously demands dedicated regulatory affairs expertise that most manufacturers lack internally. Missteps lead to resubmissions, delays, and lost first-mover advantage.
Taevas assigns dedicated regulatory affairs managers per market, pre-screening dossiers to eliminate deficiencies before submission.
Focused on advanced medical technologies, supported by clinical validation, regulatory compliance, and strong hospital and clinician networks.
MRI, CT, ultrasound, and digital X-ray systems requiring IEC 60601 compliance and DICOM integration for clinical environments.
Electrosurgical units, laparoscopic systems, and robotic-assisted platforms classified under Class IIb or Class III in most jurisdictions.
Vital signs monitors, ventilators, and infusion pumps requiring rigorous alarm management standards and ICU-grade reliability certification.
Cochlear implants, hearing aids, and endoscopic ENT instruments subject to active implantable device regulations in EU and US markets.
Phacoemulsification systems, intraocular lenses, and ophthalmic lasers regulated as Class III devices requiring clinical evaluation data.
Joint replacement implants, spinal fixation systems, and bone cement requiring biocompatibility testing per ISO 10993 standards.
Pacemakers, cardiac catheters, and coronary stents classified as high-risk implantables requiring PMA or Class III notified body review.
Deep brain stimulators, EEG systems, and neuronavigation platforms subject to active implantable and software as a medical device regulations.
Dental implants, CAD/CAM milling units, and intraoral scanners requiring ISO 13485 quality management and country-specific dental device listings.
Electrotherapy units, exoskeletons, and robotic rehabilitation platforms classified under Class I or IIa with specific usability engineering requirements.
Blood glucose monitors, CPAP devices, and wearable ECG patches requiring IVD or general medical device registration and remote data compliance.
Available individually or as a full end-to-end market entry programme.
Device-class-specific market sizing, competitive landscape analysis, and hospital procurement mapping across target markets to validate commercial opportunity before investment.
End-to-end technical dossier preparation and submission management for FDA 510(k), EU MDR CE marking, CDSCO, NMPA, and other national competent authorities.
Appointment of Authorised Representatives and Registered Agents as required under EU MDR, UK MDR, and other jurisdictions to fulfil mandatory in-country legal obligations.
Customs classification under HS codes for medical devices, import licence management, and cold-chain-compliant freight coordination for temperature-sensitive equipment.
ISO 13485-compliant medical device storage with lot traceability, expiry management, and UDI-ready inventory systems across regional distribution hubs.
Identification, qualification, and ongoing management of in-country medical device distributors, including training on device handling, clinical positioning, and tender processes.
Support for contract manufacturing agreements, local assembly partnerships, and transfer of technical files to meet local content requirements in key markets.
Clinician-facing marketing programmes, KOL engagement strategies, and hospital education campaigns tailored to device category and target specialty.
In-country clinical sales representative deployment, tender bid management, and hospital formulary inclusion support to convert registrations into revenue.
| Market | Regulatory Body |
|---|---|
🇺🇸United States | FDA – Center for Devices and Radiological Health (CDRH) |
🇪🇺European Union | European Commission / Notified Bodies (e.g. BSI, TÜV SÜD) |
🇮🇳India | Central Drugs Standard Control Organisation (CDSCO) |
🇨🇳China | National Medical Products Administration (NMPA) |
🇸🇦Saudi Arabia | Saudi Food and Drug Authority (SFDA) |
🇦🇺Australia | Therapeutic Goods Administration (TGA) |
🇧🇷Brazil | Agência Nacional de Vigilância Sanitária (ANVISA) |
Click any phase to explore. Regulatory and commercial workstreams run in parallel.
We analyse device classification, competitive landscape, reimbursement pathways, and hospital procurement dynamics in each target market to build a prioritised entry roadmap.
Clients avoid entering markets where registration timelines or pricing environments make commercial viability unlikely.

You manage multi-market submission pipelines under EU MDR, FDA, and CDSCO simultaneously with a lean internal team. Coordinating technical files, clinical evaluations, and authority queries across time zones is stretching capacity. You need a trusted partner who can own the in-country regulatory process end-to-end.
Taevas assigns a dedicated regulatory affairs manager per market, handling submissions, query responses, and certificate maintenance so your team focuses on product development.

Your devices are registered in several markets but revenue is not materialising because distributors lack clinical credibility and hospital procurement relationships. You need boots on the ground who understand hospital tendering, clinical champions, and budget cycles. Time-to-revenue is your primary KPI.
Taevas deploys in-country clinical sales support, manages tender submissions, and leverages established hospital procurement contacts to convert registrations into purchase orders.

You source medical devices for multiple clinical departments and need suppliers who can demonstrate regulatory compliance, provide post-market documentation, and support clinical training. Navigating international manufacturers with no local presence creates risk in your supply chain and compliance obligations.
Taevas acts as the compliant local interface between international device manufacturers and your procurement process, providing all required regulatory and post-market documentation.
Our teams include former regulatory affairs specialists and clinical application engineers with direct experience across device classes from Class I consumables to Class III implantables.
Taevas maintains active relationships with procurement committees and clinical department heads across public and private hospital networks in 24+ markets.
Every market is staffed by local regulatory professionals who maintain direct working relationships with national competent authorities and notified bodies.
Our pre-built submission templates, authority relationships, and parallel-processing approach reduce average time to first registration by up to 60% compared to independent entry.
All warehousing, distribution, and post-market activities operate within an ISO 13485-certified quality management system, ensuring full supply chain compliance.
From initial submission through post-market surveillance, periodic safety updates, and registration renewals, Taevas maintains continuous compliance so your market access is never interrupted.

Class III Orthopaedic Implant
Full registration secured in India, Australia, Singapore, Thailand, Indonesia, and South Korea within 14 months, with first hospital tender won in month 16.

Class IIb Patient Monitor
EU MDR CE certificate issued in 9 months. Saudi SFDA and UAE MoH registrations followed within 5 months, enabling distribution to 38 hospitals in the GCC region.

Class III Diagnostic Imaging System
ANVISA registration completed in 11 months using Taevas technical file preparation and local AR appointment, with first commercial sale in Brazil within 6 weeks of approval.
Whether you are filing your first international submission or scaling across a new region, Taevas provides the regulatory expertise, in-country infrastructure, and clinical networks to make it happen efficiently and compliantly.